Absorbable polymer blend compositions having enhanced nucleation rates

Patent metadata

Field	Value
Publication number	US-9873790-B1
Application number	US-201615345034-A
Country	US
Kind code	B1
Filing date	Nov 7, 2016
Priority date	Nov 7, 2016
Publication date	Jan 23, 2018
Grant date	Jan 23, 2018

Abstract

Novel absorbable, semi-crystalline, polymer blend compositions are disclosed exhibiting enhanced crystallization and nucleation rates. Also disclosed are medical device constructs, such as fibers made from such blends. The blends have a first absorbable polymeric component having a first molecular weight distribution and a second absorbable polymeric component which has an ultrahigh molecular weight distribution. The first and second polymeric components may be the same polymer.

First claim

We claim:

1. An absorbable semi-crystalline polymer blend composition, comprising:
(a) a first amount of a first absorbable polymer having a first crystallization rate, a first molecular weight distribution and a weight average molecular weight from about 50,000 to about 200,000 Daltons; and,
(b) a second amount of a second absorbable ultrahigh molecular weight polymer having a second crystallization rate, a second molecular weight distribution and a weight average molecular weight from about 300,000 to about 3,000,000 Daltons,
wherein the weight average molecular weight ratio of said first molecular weight distribution to said second molecular weight distribution is at least about one to three and wherein a substantially homogeneous blend of said first and second components is formed in a ratio of between about 99.9/0.1 to about 95/5 weight/weight percent, said substantially homogeneous blend having a crystallization rate greater than each of said first crystallization rate and said second crystallization rate.

2. The absorbable polymer blend composition of claim 1 , wherein the first and second components comprise lactide—rich homopolymers and copolymers.

3. The absorbable polymer blend composition of claim 1 , wherein the first and second components comprise p-dioxanone—rich homopolymers and copolymers.

4. The absorbable polymer blend composition of claim 1 , wherein the first and second absorbable polymers are the same polymer.

5. The absorbable polymer blend composition of claim 1 , wherein the first and second absorbable polymers comprise polymers selected from the group consisting of polylactic acid or polylactide, polyglycolic acid or polyglycolide, poly(p-dioxanone), various poly(ether esters), poly(amino acids), copolymers and terpolymers of lactide, glycolide, p-dioxanone, trimethylene carbonate, ε-caprolactone, poly(ethylene diglycolate), poly(ethoxyethylene diglycolate), polyethylene glycol, and combinations thereof.

6. A medical device comprising an absorbable semi-crystalline polymer blend composition, said blend composition comprising:
(a) a first amount of a first absorbable polymer having a first crystallization rate, a first molecular weight distribution and a weight average molecular weight from about 50,000 to about 200,000 Daltons; and,
(b) a second amount of a second absorbable ultrahigh molecular weight polymer having a second crystallization rate, a second molecular weight distribution and a weight average molecular weight from about 300,000 to about 3,000,000 Daltons,
wherein the weight average molecular weight ratio of said first molecular weight distribution to said second molecular weight distribution is at least about one to three, and

wherein a substantially homogeneous blend of said first and second components is formed in a ratio of between about 99.9/0.1 to about 95/5 weight/weight percent, said substantially homogeneous blend having a crystallization rate greater than each of said first crystallization rate and said second crystallization rate.

7. The medical device of claim 6 comprising a device selected from the group consisting of sutures, clips, staples, pins, screws, fibers, fabrics, meshes, clamps, plates, hooks, buttons, snaps, prosthetics, grafts, injectable polymers, vertebrae discs, anchoring devices, suture anchors, septal occlusion devices, injectable defect fillers, preformed defect fillers, bone waxes, cartilage replacements, spinal fixation devices, drug delivery devices, a foams, and films.

8. The medical device of claim 6 , wherein the first and second components comprise lactide—rich homopolymers and copolymers.

9. The medical device of claim 6 , wherein the first and second components comprise p-dioxanone—rich homopolymers and copolymers.

10. The medical device of claim 6 , wherein the first and second absorbable polymers are the same polymer.

11. The medical device of claim 6 , wherein the first and second absorbable polymers comprise polymers selected from the group consisting of polylactic acid or polylactide, polyglycolic acid or polyglycolide, poly(p-dioxanone), various poly(ether esters), poly(amino acids), copolymers and terpolymers of lactide, glycolide, p-dioxanone, trimethylene carbonate, ε-caprolactone, poly(ethylene diglycolate), poly(ethoxyethylene diglycolate), polyethylene glycol, and combinations thereof.

12. A method of making an absorbable semi-crystalline polymer blend, comprising the step of:
melt processing an absorbable polymer blend, the polymer blend comprising:
(a) a first amount of a first absorbable polymer having a first crystallization rate, a first molecular weight distribution and a weight average molecular weight from about 50,000 to about 200,000 Daltons; and,
(b) a second amount of a second absorbable ultrahigh molecular weight polymer having a second crystallization rate, a second molecular weight distribution and a weight average molecular weight from about 300,000 to about 3,000,000 Daltons,
wherein the weight average molecular weight ratio of said first molecular weight distribution to said second molecular weight distribution is at least about one to three, and

wherein a substantially homogeneous blend of said first and second component is formed in a ratio of between about 99.9/0.1 to about 95/5 weight/weight percent, said substantially homogeneous blend having a crystallization rate greater than each of said first crystallization rate and said second crystallization rate.

13. The method of claim 12 , wherein melt-processing includes melt blending, extruding, melt spinning, compression molding, melt blowing or injection molding the blended first and second components at a temperature above their melting temperatures, followed by cooling and crystallizing the blend.

14. The method of claim 12 , wherein the first and second components comprise lactide—rich homopolymers and copolymers.

15. The method of claim 12 , wherein the first and second components comprise p-dioxanone—rich homopolymers and copolymers.

16. The method of claim 12 , wherein the first and second absorbable polymers are the same polymer.

17. The method of claim 12 , wherein the first and second absorbable polymers comprise polymers selected from the group consisting of polylactic acid or polylactide, polyglycolic acid or polyglycolide, poly(p-dioxanone), various poly(ether esters), poly(amino acids), copolymers and terpolymers of lactide, glycolide, p-dioxanone, trimethylene carbonate, ε-caprolactone, poly(ethylene diglycolate), poly(ethoxyethylene diglycolate), polyethylene glycol, and combinations thereof.

18. A method of making a medical device, comprising the step of:
forming a medical device by melt-processing or heat treating an absorbable semi-crystalline polymer blend over a temperature range of between about 80° C. to about 260° C., said polymer blend comprising:
(a) a first amount of a first absorbable polymer having a first crystallization rate, a first molecular weight distribution and a weight average molecular weight from about 50,000 to about 200,000 Daltons; and,
(b) a second amount of a second absorbable ultrahigh molecular weight polymer having a second crystallization rate, a second molecular weight distribution and a weight average molecular weight from about 300,000 to about 3,000,000 Daltons,
wherein the weight average molecular weight ratio of said first molecular weight distribution to said second molecular weight distribution is at least about one to three, and

wherein a substantially homogeneous blend of said first and second component is formed in

Assignees

• Ethicon Inc

Inventors

• Andjelic Sasa
• Keilman Kenneth

Classifications

• D01F6/92

  of polyesters · CPC title

• C08J3/005

  Processes for mixing polymers · CPC title

• D01F6/94

  of other polycondensation products · CPC title

• C08G63/08

  Lactones or lactides · CPC title

• C08L67/04 Primary

  Polyesters derived from hydroxycarboxylic acids, e.g. lactones (C08L67/06 takes precedence) · CPC title